Hannah R Wardill
Overview
Explore the profile of Hannah R Wardill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bellas O, Cao K, Bowen J, Smid S, Shakib S, Crawford G, et al.
BMJ Open
. 2025 Mar;
15(3):e089336.
PMID: 40032389
Introduction: Many chemotherapy agents used to treat advanced cancer are inherently mucotoxic, causing breakdown of the gastrointestinal mucosa (gastrointestinal mucositis (GI-M)) and lead to a constellation of secondary complications including...
2.
Ariaee A, Koentgen S, Wardill H, Hold G, Prestidge C, Armstrong H, et al.
eGastroenterology
. 2025 Feb;
2(2):e100055.
PMID: 39944472
Inflammatory bowel disease (IBD) is characterised by chronic inflammation in the gastrointestinal tract, with unclear aetiology but with known factors contributing to the disease, including genetics, immune responses, environmental factors...
3.
Ariaee A, Wardill H, Wignall A, Prestidge C, Joyce P
Foods
. 2025 Jan;
13(24.
PMID: 39767129
In the original publication [...].
4.
Gardiner B, Wardill H, OConnor G, Hargrave D, Lett A
Clin Nutr
. 2024 Dec;
44:86-100.
PMID: 39644740
Background & Aims: Cancer therapy is associated with a range of toxicities that severely impact patient well-being and a range of clinical outcomes. Dietary fibre/prebiotics characteristically improve the gastrointestinal microenvironment,...
5.
Dorraki M, Liao Z, Abbott D, Psaltis P, Baker E, Bidargaddi N, et al.
JACC Adv
. 2024 Oct;
3(9):101180.
PMID: 39372477
Background: Robust and accurate prediction of cardiovascular disease (CVD) risk facilitates early intervention to benefit patients. The intricate relationship between mental health disorders and CVD is widely recognized. However, existing...
6.
Stringer A, Hargreaves B, Amaral Mendes R, Blijlevens N, Bruno J, Joyce P, et al.
Support Care Cancer
. 2024 Jul;
32(8):558.
PMID: 39080025
Advances in the treatment of cancer have significantly improved mortality rates; however, this has come at a cost, with many treatments still limited by their toxic side effects. Mucositis in...
7.
Dikeocha I, Wardill H, Coller J, Bowen J
Clin Nutr ESPEN
. 2024 Jul;
63:462-475.
PMID: 39018241
Background & Aims: Optimizing treatment efficacy is still a critical part in advancing the treatment of breast cancer. Dietary interventions have drawn significant attention for their potential to increase tumor...
8.
Gobbo M, Joy J, Guedes H, Shazib M, Anderson C, Abdalla-Aslan R, et al.
Expert Opin Pharmacother
. 2024 May;
25(6):727-742.
PMID: 38808634
Introduction: The introduction of targeted therapy and immunotherapy has tremendously changed the clinical outcomes and prognosis of cancer patients. Despite innovative pharmacological therapies and improved radiotherapy (RT) techniques, patients continue...
9.
Scott J, Li A, Wardill H
Curr Opin Support Palliat Care
. 2024 Apr;
18(2):73-77.
PMID: 38652454
Purpose Of Review: Disruption of the precious ecosystem of micro-organisms that reside in the gut - the gut microbiota - is rapidly emerging as a key driver of the adverse...
10.
Ariaee A, Wardill H, Wignall A, Prestidge C, Joyce P
Foods
. 2024 Apr;
13(7).
PMID: 38611345
Inulin, a non-digestible polysaccharide, has gained attention for its prebiotic properties, particularly in the context of obesity, a condition increasingly understood as a systemic inflammatory state linked to gut microbiota...